Publication | Closed Access

In vivo selection of intrabodies specifically targeting protein–protein interactions: A general platform for an “undruggable” class of disease targets☆

Protein–protein InteractionsDrug TargetDrug TargetingMedicineImmunologyVivo SelectionBiomolecular InteractionPharmacologyDisease Targets☆Quantitative Pharmacology